Takeda Pharmaceutical's net profit FY 2013-2022
In the 2022 fiscal year, the Japanese pharmaceutical company Takeda Pharmaceutical Co., Ltd. recorded net profits of approximately 317 billion Japanese yen, an increase from around 230 billion yen in the previous fiscal year.
The company focuses mainly on the therapeutic areas of oncology, gastroenterology, and neuroscience.